About Korio
Korio is a company based in San Francisco (United States) founded in 2021 by Chuck Harris and Ryan Keane. Korio has raised $12.3 million across 2 funding rounds from investors including BIP Ventures, Excelerate Health Ventures and Boston Millennia Partners. Korio operates in a competitive market with competitors including N-SIDE, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others.
- Headquarter San Francisco, United States
- Founders Chuck Harris, Ryan Keane
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.3 M (USD)
in 2 rounds
-
Latest Funding Round
$5.5 M (USD), Series A
Aug 23, 2024
-
Investors
BIP Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Korio
Unlock access to complete
Unlock access to complete
Funding Insights of Korio
Korio has successfully raised a total of $12.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.5 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Korio
Korio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include BIP Ventures, Excelerate Health Ventures and Boston Millennia Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided by BIP Ventures.
|
Locked | Locked | Locked | |
|
Venture capital is provided for AI-driven healthcare innovations.
|
Locked | Locked | Locked | |
|
US-focused private equity and venture capital investments are managed.
|
Locked | Locked | Locked |
Investor details for Korio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Korio
Investment portfolio details for Korio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Korio
Detailed financials for Korio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Korio Comparisons
Peer comparison for Korio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Korio
Korio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as N-SIDE, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud and AI-based analytics are offered for supply chain optimization.
|
|
| Locked | Locked | Locked |
Interactive Response Technology systems are provided for clinical trials.
|
|
| Locked | Locked | Locked |
Software solutions for pre-clinical scientific data management in life sciences.
|
|
| Locked | Locked | Locked |
Delivers comprehensive solutions for clinical trial supply management.
|
|
| Locked | Locked | Locked |
Software products and services for the pharmaceutical and biotechnology industries
|
Detailed competitors of Korio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Korio
Complete news archive for Korio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Korio
Korio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Korio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ryan Keane is the current CEO of Korio. They have also founded this company.
Korio is a funded company, having raised a total of $12.3M across 2 funding rounds to date.
Korio was founded in 2021 in San Francisco, United States, as a provider in the health technology sector. An IRT platform is offered by the company for clinical trial randomization, supply management, and design. Operations focus on supporting pharmaceutical and biotech firms with tools for efficient trial logistics. The domain korioclinical.com is used for its online presence. Co-founders include Chuck Harris and Ryan Keane, with Keane serving as CEO.
Korio's top competitors include Endpoint Clinical, N-SIDE and Clinapps.
Korio has 3 investors. Key investors include BIP Ventures, Excelerate Health Ventures, and Boston Millennia Partners.